Mumbai: Shares of Divi’s Laboratories Ltd on Thursday fell as much as 6.3% to hit a low of over five months after the company said the US Food and Drug Administration (USFDA) has issued Form 483 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback